A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: GB491 combined with Letrozole|DRUG: Placebo combined with Letrozole
Sponsor: Genor Biopharma Co., Ltd.